These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 36135086

  • 1. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.
    Wang Y, Huang X, Chen S, Jiang H, Rao H, Lu L, Wen F, Pei J.
    Curr Oncol; 2022 Sep 15; 29(9):6573-6593. PubMed ID: 36135086
    [Abstract] [Full Text] [Related]

  • 2. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M, Mu J, Wang J, Zhou Q, Wang J.
    Front Oncol; 2022 Sep 15; 12():961213. PubMed ID: 35965536
    [Abstract] [Full Text] [Related]

  • 3. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y, Lu L, Liang X, Chen Y.
    World J Surg Oncol; 2022 Apr 12; 20(1):118. PubMed ID: 35413978
    [Abstract] [Full Text] [Related]

  • 4. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun 12; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 5. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
    Wang F, Lin H, Su Q, Li C.
    World J Surg Oncol; 2022 Sep 01; 20(1):275. PubMed ID: 36050740
    [Abstract] [Full Text] [Related]

  • 6. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X, Ye Z, Xiao G, He T.
    Comput Biol Med; 2023 Jun 01; 159():106905. PubMed ID: 37060773
    [Abstract] [Full Text] [Related]

  • 7. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y, Zhang Q, Zhang H, Kong F.
    Funct Integr Genomics; 2023 Jan 14; 23(1):38. PubMed ID: 36640225
    [Abstract] [Full Text] [Related]

  • 8. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C, Zhang K, Gong Y, Wu Q, Zhang Y, Dong Y, Li D, Wang Z.
    Front Pharmacol; 2023 Jan 14; 14():1200054. PubMed ID: 37377924
    [Abstract] [Full Text] [Related]

  • 9. Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer.
    Xu Q, Liu T, Wang J.
    Genes (Basel); 2022 Nov 09; 13(11):. PubMed ID: 36360316
    [Abstract] [Full Text] [Related]

  • 10. Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs.
    Yalimaimaiti S, Liang X, Zhao H, Dou H, Liu W, Yang Y, Ning L.
    BMC Bioinformatics; 2023 Mar 06; 24(1):81. PubMed ID: 36879187
    [Abstract] [Full Text] [Related]

  • 11. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma.
    Cheng X, Zeng Z, Yang H, Chen Y, Liu Y, Zhou X, Zhang C, Wang G.
    BMC Cancer; 2023 Jan 30; 23(1):105. PubMed ID: 36717792
    [Abstract] [Full Text] [Related]

  • 12. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A, Huang Z, Zhang R, Lu H, Wang J, Cao J, Feng Q.
    Comput Math Methods Med; 2022 Jan 30; 2022():1709918. PubMed ID: 35116071
    [Abstract] [Full Text] [Related]

  • 13. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z, Qian W, Wang S, Ji D, Wang Q, Li J, Peng W, Gu J, Hu T, Ji B, Zhang Y, Wang S, Sun Y.
    Cell Physiol Biochem; 2018 Jan 30; 49(5):1778-1791. PubMed ID: 30231249
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D, Lu W, Zhuo Z, Wang Y, Zhang W, Zhang M.
    BMC Med Genomics; 2023 May 05; 16(1):96. PubMed ID: 37143115
    [Abstract] [Full Text] [Related]

  • 15. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
    Chen F, Li Z, Deng C, Yan H.
    J Transl Med; 2019 Aug 30; 17(1):299. PubMed ID: 31470869
    [Abstract] [Full Text] [Related]

  • 16. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L, Wang Q, Wang L, Hu Z, Yang C, Li Y, Wang Z, Li Y.
    BMC Med Genomics; 2023 Mar 22; 16(1):58. PubMed ID: 36949429
    [Abstract] [Full Text] [Related]

  • 17. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y, Gong P, Su L, Zhang M.
    Sci Rep; 2023 Nov 27; 13(1):20870. PubMed ID: 38012210
    [Abstract] [Full Text] [Related]

  • 18. Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma.
    Xi J, Zhang H, Li Y, Su H, Chen X, Liang X.
    Medicine (Baltimore); 2022 Sep 30; 101(39):e30681. PubMed ID: 36181111
    [Abstract] [Full Text] [Related]

  • 19. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs.
    Tu H, Zhang Q, Xue L, Bao J.
    Genes (Basel); 2022 Nov 25; 13(12):. PubMed ID: 36553481
    [Abstract] [Full Text] [Related]

  • 20. Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.
    Xu C, Chen A, Mao C, Cui B.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr 25; 52(2):139-147. PubMed ID: 37283097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.